Arrhythmogenic left atrial cellular electrophysiology in a murine genetic long QT syndrome model
about
Emerging directions in the genetics of atrial fibrillationMechanisms of ranolazine's dual protection against atrial and ventricular fibrillationNew treatment options for late Na current, arrhythmias, and diastolic dysfunctionLate Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial FibrillationAberrant sodium influx causes cardiomyopathy and atrial fibrillation in miceThe Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic TargetsEHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapyA truncating SCN5A mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation.Light phase-restricted feeding slows basal heart rate to exaggerate the type-3 long QT syndrome phenotype in mice.Common and rare variants in SCN10A modulate the risk of atrial fibrillation.Atrial tachyarrhythmia in Rgs5-null mice.Genetic mechanisms of atrial fibrillation: impact on response to treatmentPITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers.Atrial fibrillation: mechanisms, therapeutics, and future directions.Genomics of Atrial Fibrillation.Novel molecular targets for atrial fibrillation therapy.A focus on antiarrhythmic properties of ranolazine.Ion channels, long QT syndrome and arrhythmogenesis in ageing.Murine Electrophysiological Models of Cardiac Arrhythmogenesis.An automated system using spatial oversampling for optical mapping in murine atria. Development and validation with monophasic and transmembrane action potentials.Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts.TREK-1 (K2P2.1) K+ channels are suppressed in patients with atrial fibrillation and heart failure and provide therapeutic targets for rhythm control.Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.Ranolazine for atrial fibrillation: buy one get three beneficial mechanisms!Triggered activity in atrial myocytes is influenced by Na+/Ca2+ exchanger activity in genetically altered mice.Cellular and molecular correlates of ectopic activity in patients with atrial fibrillation.EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.Distinct Occurrence of Proarrhythmic Afterdepolarizations in Atrial Versus Ventricular Cardiomyocytes: Implications for Translational Research on Atrial ArrhythmiaAtrial Fibrillation Mechanisms and Implications for Catheter Ablation
P2860
Q26852051-0219B1BA-8CFA-47D0-90CD-AB6497F66C91Q26995558-D33E9DBF-0F42-4CC3-AC49-CC7A7AA5ED98Q27012532-A22C3F59-768B-474F-9C7E-2E416D0B60AFQ27303632-76EDB351-3499-426C-8412-2CE7E8980D6AQ27329882-29E36F89-E005-44CA-8184-55FD384E456FQ28080690-B2223E2A-67B4-4DCD-914C-5F34C372AF40Q30375302-1F1E6F80-0C13-4906-9445-CBE5F1A53E33Q33706395-611B604F-6E3F-4F01-BDD3-DEB70A56BBDBQ33752259-648D7CED-C98D-44CF-89B0-66C4BDF431D9Q34726900-649678E7-2F7E-446F-80B9-F17705C70701Q35352846-27C9B170-9CB1-430E-915F-885ECC80D097Q36373654-2B71B3B7-C269-46B5-BC5B-983CB7464721Q36876093-2B97A515-5FB5-4BC3-B166-8F29AD23E807Q37358608-91760BC1-284A-443A-AC24-24EB45B0758EQ37590158-692A2A73-13A9-4F5E-88DC-121CB92B35A9Q37745006-E2D6FAB9-ACE6-47B5-92C1-C8DA246D131FQ37998312-138F9403-DE29-4ECF-B8B8-6C333EDE9A86Q38001669-F0B91A50-D61B-44D7-B4AC-84188AE5EA73Q38778017-E2038619-60E4-4420-B3C9-32D7FB1BDEDDQ39038606-84260790-BFBC-4767-97C1-0E01F15ACECEQ41871786-BABF191D-44E7-49D1-81A1-12D1FAC0853AQ41910718-E6D2954D-50F4-4B00-8943-7402BC7A9B52Q42008383-7ED7E093-FC93-4FD8-9E4D-E80307DC4D83Q42234927-07A9DDCE-12CD-4E32-958A-C13527E624BFQ42355641-918CDCA0-E464-423A-A04E-C15E0A703E0DQ49172061-89A7741F-B51B-44EC-ACB9-B8E84D9D7715Q51305092-87D599AA-56BB-45D0-B974-C4753580467AQ55638585-FC029781-9BE8-4621-B2FD-C3740612B63DQ58728367-0DAFB172-AF1E-4C4B-BC08-9341A1B3D215Q59136309-9316E333-CE7F-4627-B978-ACA42FB2A371
P2860
Arrhythmogenic left atrial cellular electrophysiology in a murine genetic long QT syndrome model
description
article
@en
im Juni 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2011
@uk
name
Arrhythmogenic left atrial cel ...... genetic long QT syndrome model
@en
Arrhythmogenic left atrial cel ...... genetic long QT syndrome model
@nl
type
label
Arrhythmogenic left atrial cel ...... genetic long QT syndrome model
@en
Arrhythmogenic left atrial cel ...... genetic long QT syndrome model
@nl
prefLabel
Arrhythmogenic left atrial cel ...... genetic long QT syndrome model
@en
Arrhythmogenic left atrial cel ...... genetic long QT syndrome model
@nl
P2093
P2860
P50
P356
P1476
Arrhythmogenic left atrial cel ...... genetic long QT syndrome model
@en
P2093
Denis Chartier
James Elber Duverger
Patrice Naud
Philippe Comtois
Xiao Yan Qi
P2860
P356
10.1093/CVR/CVR166
P577
2011-06-14T00:00:00Z